Awards/PROJECT GRANT (B)

$60,745,274

Department of Health and Human Services·National Institutes of Health

biotechactiveONGOING · MOD OF 1996 CONTRACT

WORK BEGAN1996-12-01·LATEST ACTION2026-04-06·SOURCEUSASPENDING·SOURCE IDASST_NON_P30CA016087_075

Award description

CANCER CENTER SUPPORT GRANT

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

The latest funding increment supporting cancer research and research infrastructure at NYU's cancer center since 1996.

Sub-sectors

cancer-researchresearch-infrastructurecancer-center

Why this matters

Cancer research advances oncology treatments and precision medicine, reinforcing U.S. biotech innovation and clinical care capabilities.

Supply-chain signal

Sustains demand for laboratory equipment, reagents, bioinformatics tools, and pharmaceutical partnerships in the research ecosystem.

U.S.–China competition angle

Maintains U.S. leadership in cancer research and precision medicine, areas where China is rapidly increasing R&D investment.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-07. Cost: $0.022574.

Period of performance

Start

1996-12-01

End

2029-02-28

Status

activein 973 days

Recipient

Other awards from this recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier ASST_NON_P30CA016087_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.